Table 2.

Hematological test results for the 10 cases included in the study.

Hematological tests1	Patient #1	Patient #2	Patient #3	Patient #4	Patient #5	Patient #6	Patient #7	Patient #8	Patient #9	Patient #10
Blood routine examination
WBC (109/L) [3.5–9.5]2	14.79	6.16	18.79	16.51	8.32	14.42	29.72	3.39	10.83	23.35
HGB (g/L) [130–175]	87	73	142	121	117	109	141	131	112	92
PLT (109/L) [125–350]	318	25	178	90	60	32	210	42	64	251
Lymphocyte ratio (%) [20–50]	1.9	4.8	1.8	6.7	9.9	0.5	4.2	3.5	1.5	8.7
Lymphocyte count (109/L) [1.1–3.2]	0.28	0.3	0.34	1.11	0.82	0.07	1.25	0.12	0.16	2.03
PCT (ng/mL) [<0.064]	2.7	2.5	0.13	23	22	0.44	3.5	0.59	<0.07	31
CRP (mg/L) [<5]	59.16	165	60	119	152	25	450	74	30	89
IL-6 (pg/mL) [0–11.09]	10.46	585.05	1.5	21.01	175	436.58	133.26	7.87	111.48	321.84
BNP (pg/mL) [age-adjusted]3	5,110	20,500	1,930	248,000	161,000	1,450	735	1,565	797	7,930
Cr (μmol/L) [20–115]	315	244	66	73	238	55	52	60	107	101
Urea (mmol/L) [2.2–8.2]	19.33	24.12	9.9	10.38	17.2	20.68	7.63	10.4	19.71	12.77
PT (s) [8.8–13.6]	11	11.6	10.7	13.1	11.1	12.1	15.8	12.5	13.4	15.1
APTT (s) [26–40]	26.3	30.4	24.5	27.8	33.7	29.9	29	30	28.9	67.4
D-dimer (mg/L) DDU [0–0.55]	4.82	0.82	6.09	5.87	3.31	0.32	0.96	6.47	11.19	44.13
Glu (mmol/L) [3.6–6.1]	17.61	6.32	6.5	16.3	10.86	4.25	20.9	7.29	8.95	17.08
ALT (U/L) [0–40]	6	1	10	201	865	55	30	30	18	202
TBIL (μmol/L) [0–25]	10.4	8.6	13.3	16.6	10.6	28.3	29.3	18.5	7	14.6
Lac (mmol/L) [0.5–2.2]	1.1	1.1	1.6	1.5	2.6	1.2	1.8	1.7	1.2	15
TNT (ng/mL) [0–0.014]	0.064	0.066	0.018	0.1	9.53	0.06	0.013	0.015	NA	0
TNI (µg/L) [0.010–0.023]	0.019	0.02	<0.010	0.17	9.5	0.037	0.018	<0.010	0.021	0.062
CK-MB (ng/mL) [2–7.2]	4.2	<2	4.4	<2	395	10	3.01	3.8	<2	3.4
Lymphocyte analysis
T (%) [50–81]	77.24	80.72	55.03	71.71	98.07	62.99	61.77	46.64	63.84	78.05
CD4+T (%) [27–51]	33.17	61.58	23.34	49.01	28.95	19.14	37.25	30.25	34.09	31.98
CD8+T (%) [15–44]	39.2	18.12	27.23	21.91	66.5	43.21	22.83	16.96	28.93	41.32
B (%) [5–8]	17.23	17.28	35.2	14.72	0	13.43	33.62	44.29	18.39	11.05
NK (%) [7–40]	12.5	1.36	9.49	12.53	1.56	50.41	3.17	5.48	11.47	5.86
CD4+T/CD8+T [0.71–2.78]	0.85	3.4	8.11	2.24	0.44	0.44	1.63	1.78	1.18	0.68
Lym (/µL) [1,530–3,700]	434.07	263	319.81	883	1,909	63.74	1,169.07	219	142.36	340.34
T (/µL) [955–2,860]	335.28	213	174.69	632	1,872	40.15	703.91	102	90.89	265.62
CD4+T (/µL) [550–1,440]	170.37	156	74.08	430	563	12.1	424.48	65	48.53	108.84
CD8+T (/µL) [320–1,250]	201.37	46	86.44	191	1,288	27.32	260.11	37	41.18	161.05
B (/µL) [90–560]	74.81	47	111.74	132	0	8.56	379.69	99	26.18	33.97
NK (/µL) [150–1,100]	12.28	4	30.13	112	29	11.8	36.16	12	16.32	18.02

ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; ARDS, acute respiratory distress syndrome; B, B lymphocyte; BNP, N-terminal pro-brain natriuretic peptide; CK-MB, creatine kinase-MB; Cr, creatinine; CRP, C-reactive protein; Glu, glucose; HGB, hemoglobin; IL-6, interleukin-6; Lac, lactic acid; Lym, Lymphocyte; NA, not available; NK, natural killer cell; PCT, procalcitonin; PLT, platelet; PT, prothrombin time; T, T lymphocyte; TBIL, total bilirubin; TNI, high-sensitivity cardiac troponin I; TNT, high-sensitivity cardiac troponin T; WBC, white blood cell.

¹The case sequence is identical to Table 1 .

²Normal reference range of our laboratory was given in square brackets. The same below.

³Normal reference range of BNP in our laboratory: <300 pg/mL (<50 years); <900 pg/mL (50–75 years); <1,800 pg/mL (>75 years).